A recent meta-analysis reported that mean IL-6 concentrations raised to nearly threefold higher in complicated versus uncomplicated COVID-19 patients and 9 out of 10 studies examined showed elevated IL-6 levels associated with worse prognosis [116]. This evidence concerns the gene IL6 and COVID-19.